Categories: News

Jungbunzlauer to acquire from International Flavors & Fragrances, Inc. multipurpose site in Thomson, IL

 – establishing U.S. manufacturing footprint –

- Advertisement -

BASEL, Switzerland, Sept. 2, 2025 /PRNewswire/ — Jungbunzlauer, a global leader in high-quality, sustainable ingredients from natural sources, announced today the signing of a binding and definitive agreement to acquire the multipurpose production site in Thomson, IL from International Flavors & Fragrances, Inc.  (IFF).

- Advertisement -

“This acquisition is an important step in delivering on our strategic capacity expansion in North America,” said Bruno Tremblay, Chief Executive Officer of Jungbunzlauer. “Establishing a U.S. manufacturing footprint allows us to work closer to many of our U.S. customers, better understand their challenges and deliver solutions that truly make a difference.”

- Advertisement -

The asset deal  does not include any of IFF’s commercial business, product lines or employees, and terms of the deal were not disclosed.

- Advertisement -

“Upon closing the transaction, our immediate focus will be on preparing the site for our specific production needs,” added Tremblay. “As we finalise our operational plans, we look forward to sharing updates, including information about future hiring.”

- Advertisement -

The transaction is expected to close in early Q4 2025, subject to receipt of all applicable regulatory approvals and the satisfaction of other customary closing conditions.

- Advertisement -

About Jungbunzlauer

- Advertisement -

Jungbunzlauer is a leading producer of high-quality, sustainable ingredients from natural sources, serving industries from food and beverage, to nutrition, health, home and personal care, among others. Leading the way in developing naturally better ingredients that enhance everyday life, we are a trusted partner offering a diverse portfolio of texturants, acidulants, sweeteners, minerals, and tailored solutions to meet our customers’ evolving needs.

- Advertisement -

Headquartered in Basel, Switzerland, with state-of-the-art facilities including large-scale fermentation operations across Europe and North America, we proudly serve more than 130 countries worldwide. Founded more than 150 years ago, Jungbunzlauer has grown into a CHF 1.3 billion company, driven by nearly 1,400 dedicated colleagues committed to a healthier, more sustainable future. Learn more at www.jungbunzlauer.com.

- Advertisement -

Logo – https://mma.prnewswire.com/media/2729543/5485743/Jungbunzlauer_Logo.jpg

- Advertisement -

View original content:https://www.prnewswire.co.uk/news-releases/jungbunzlauer-to-acquire-from-international-flavors–fragrances-inc-multipurpose-site-in-thomson-il-302543214.html

- Advertisement -

Recent Posts

AvironiX Unveils AviSpray-10c, a Backpack-Sized Agricultural Spraying Drone for India’s Precision Farming Sector

CHENNAI, India, Dec. 8, 2025 /PRNewswire/ -- AvironiX Drones, a Chennai-based deep-tech drone company focused on precision farming and defence technologies, today…

3 hours ago

Abstract and Open World Partner to Launch the First National-Scale Tokenization Engine for the World’s Most Valuable Real-World Assets

For the first time, the world's most strategic assets—AI supercomputing centers, strategic real estate and…

3 hours ago

Navitas, Cyient Semiconductors enter into a strategic partnership to accelerate GaN adoption in India’s AI, Mobility, Industrial, and Energy Markets

TORRANCE, Calif. and HYDERABAD, India, Dec. 8, 2025 /PRNewswire/ -- Navitas Semiconductor Corporation (Nasdaq: NVTS),…

3 hours ago

DXC Appoints Russell Jukes as Chief Digital Information Officer to Strengthen Unified Digital Strategy

ASHBURN, Va., Dec. 8, 2025 /PRNewswire/ -- DXC Technology (NYSE: DXC), a leading enterprise technology and…

3 hours ago

Altair HyperWorks 2026 Delivers Design and Simulation at Scale with AI

Latest release enables faster, more confident design decisions at scale with accelerated simulation, AI-powered, real-time…

3 hours ago

Halia Therapeutics Announces Positive Phase 2a Data for Ofirnoflast in Lower-Risk MDS at ASH 2025

– New findings demonstrate a 72% HI-E response rate at Week 16 with meaningful hemoglobin…

3 hours ago